Torsades de pointes with pseudo–T wave alternans during rociletinib therapy: A novel manifestation of a rare side effect
Year: 2018
Type: article
Abstract: As the field of cardio-oncology evolves, it has become apparent that many of the novel therapies are associated with QT-interval prolongation. The combination of the physical properties of the drugs themselves, in addition to the clinical symptoms of nausea, vomiting, and diarrhea that cause electrolyte abnormalities, and the medications to treat those symptoms, may all contribute to prolongation of the QT interval.1
Source: HeartRhythm Case Reports
Institution: University of California, Los Angeles
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,100
Funder: Clovis Oncology
OpenAlex ID: W2886097198